Compare Nutanix Inc (NTNX) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs Tilray Brands Inc — how do they compare? Nutanix Inc trades at $64.16 (market cap $17.39B), while Tilray Brands Inc trades at $4.78 (market cap $649.42M). The key difference: Nutanix Inc is far larger — about 26.8× Tilray Brands Inc's market cap, and Nutanix Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| NTNX | TLRY | |
|---|---|---|
Market Cap | $17.39B | $649.42M |
Sector | Technology | Health |
52-Week High | $81.12 | $21.00 |
52-Week Low | $34.41 | $3.88 |
Enterprise Value | $16.90B | $816.55M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nutanix (NTNX) trades at $63.74, down 1.12% today, showing strong fundamental momentum with consistent earnings beats and robust revenue growth. The stock maintains a bullish technical outlook with moving averages supporting upward momentum, though RSI levels suggest potential overbought conditions. Recent institutional buying activity and positive analyst sentiment (62.5% buy ratings) reflect confidence in the hybrid multicloud platform's growth trajectory.
Outlook remains positive with Q4 earnings expected to beat consensus, though supply chain constraints pose near-term risks. The company's expanding profit margins and VMware migration opportunities provide upside potential, but elevated valuation metrics (P/E 67.71) require continued execution. Investors should monitor Q2 2026 earnings results due August 26th for confirmation of growth sustainability.
TLRY trades at $4.71, up 6.56% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $821M in 2025, yet the company posted a net loss of -$2.19B, reflecting profitability challenges. Recent news highlights growth initiatives, including a partnership with Wolverhampton Wanderers and a new THC pouch launch. The stock remains volatile, with a low P/S of 0.58 and P/B of 0.4, suggesting potential undervaluation amid ongoing losses.
Outlook is cautious; TLRY's path to profitability hinges on revenue growth and cost management. Risks include persistent losses, high debt, and regulatory uncertainty. Analyst consensus is mixed, with 25% buy ratings but 65% hold, indicating skepticism. Investors should weigh growth potential against financial instability and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
